Cambridge, United Kingdom

Quentin Gueranger

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mission Therapeutics Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quentin Gueranger. Retrieved from https://idiyas.com/inventor/quentin-gueranger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Quentin Gueranger in Isopeptidase Activity Measurement

Introduction

Quentin Gueranger is an accomplished inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in the measurement of isopeptidase activity. His innovative methodologies have the potential to enhance the understanding of various biological processes.

Latest Patents

Quentin Gueranger holds a patent for "Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner." This invention relates to materials and methods for high throughput monitoring of target engagement of isopeptidases, such as deubiquitylating enzymes, by small molecule inhibitors. The patent focuses on the development of high throughput assays to measure isopeptidase activity in various biological samples, including cells, animal tissues, animal tumors, human tissue, or patient-derived biopsies.

Career Highlights

Quentin is currently associated with Mission Therapeutics Limited, where he applies his expertise in biochemistry to advance research and development. His work is pivotal in creating innovative solutions that can lead to breakthroughs in therapeutic applications.

Collaborations

Quentin collaborates with notable colleagues, including Xavier Jacq and Jeanine Ann Harrigan. Their combined efforts contribute to the advancement of research in the field of isopeptidase activity and its implications in biological systems.

Conclusion

Quentin Gueranger's contributions to the measurement of isopeptidase activity represent a significant advancement in biochemistry. His innovative methodologies and collaborative efforts are paving the way for future research and potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…